Cardiac Catheters Market Size, Trends and Insights By Product (Electrophysiology Catheters, PTCA Balloons Catheters, IVUS Catheters, PTA Balloons Catheters, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Abbott Laboratories
- Boston Scientific Corporation
- Bard Medical
- Braun Melsungen AG
- Others
Reports Description
According to Custom Market Insights (CMI), The Global Cardiac Catheters Market size was estimated at 13.5 Billion in 2021 and is expected to reach USD 14.2 Billion in 2022 and is expected to hit around 25.5 Billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 7.65% from 2022 to 2030.
Cardiac catheters are used to examine heart valves or guide and observe the coronary arteries. The Product is a thin, flexible tube that facilitates the passage of medical tools for cardiovascular treatments like angioplasty and stenting via the body’s blood arteries. Also, for diagnostic and therapeutic treatments, cardiac catheters are long, thin, flexible tubes inserted into blood vessels in the arms, groin, or neck. During the comparatively safe cardiac catheterization operation, the area where the catheter is inserted may slightly bruise. During catheterization, a contrast dye is used to make the coronary arteries visible on the heart’s X-ray.
Contrarily, there are numerous kinds of cardiac catheters depending on the intricacy of heart issues, which improves the effectiveness of surgeons. Furthermore, an increase in patients with cardiac problems and unhealthy lifestyles are both contributing to the enormous growth of the cardiovascular devices sector. Throughout the anticipated era, technological developments will also drive the cardiac catheter market’s expansion.
Growth Influences:
Several instances of cardiac abnormalities have been observed, much like cardiac arrhythmias, ventricular fibrillation, and ventricular tachycardia. These instances have increased public awareness of medical device advancements and healthcare challenges. The government has also made significant investments in exploration, research, and reimbursement plans. As a result, it is projected that these factors will speed up the growth of the global market.
Massive businesses that are vying for the largest share of the cardiac catheterization market are adopting healthy trends and releasing fresh solutions that utilize cutting-edge technology for diagnosis and therapy. Spending on healthcare has also increased due to an increase in average income across the globe. Hence, these factors offer opportunities for the global market to grow.
Unhealthy lifestyle: A well-established healthcare system and an increase in chronic illnesses connected to lifestyle are key market growth drivers. Increased surgical procedures and increased knowledge of minimally invasive procedures are some factors driving market growth in developed countries. Also, the presence of a good regulatory environment has a positive impact on the growth of the catheter industry.
Diabetes is brought on by bad habits like smoking, inactivity, and eating badly. The main causes of type I and II diabetes are also a sedentary lifestyle and severe genetic alterations. Monogenic diabetes is primarily caused by a single gene mutation. Although gene mutations can occur after birth on occasion, these anomalies are frequently passed down through families.
Most of the altered genes result in decreased pancreatic function, which raises the chance of developing diabetes. One of the main techniques for treating cardiovascular disorders is percutaneous coronary intervention (PCI), which includes cardiac catheterization, angioplasty, and other treatments. One prerequisite for these treatments is the use of cardiac catheters.
Increasing older population: According to the WHO, the shift in the leading cause of death from infections to chronic non-communicable diseases, which increased life expectancy, is the reason of the sudden increase in the older population. These chronic illnesses include heart disease, dementia, congestive heart failure, high blood pressure, diabetes, arthritis, cancer, high cholesterol, and high blood sugar.
Heart disease, stroke, and cancer are the three most frequent chronic diseases, particularly in high-income nations, greatly affecting the ageing population. Moreover, both falls and obesity are becoming more common. As a result, the market for cardiac catheters has been significantly impacted by the expanding population and unhealthy lifestyle because the prevalence of diseases would increase the demand for such items in urgent care settings.
Technology advancements: Increasing the usage of cutting-edge equipment can lead to an earlier diagnosis and patient discharge. Catheters are frequently used in modern hospitals and healthcare facilities to treat potentially fatal lesions, remove calcified arterial plaque, restructure our hearts, implant new mechanical valves, even slither into our brains to prevent fatal aneurysms. Catheters are used to power many recently developed methods for restoring peripheral vasculature. Diamond-tipped, pneumatically driven catheters are the foundation of an unique orbital atherectomy procedure for treating peripheral artery disease.
The main contributor to PAD is the buildup of fatty plaque in the arteries, which narrows or blocks the blood vessels that carry blood from the heart and lungs to the limbs and legs. Devices may now penetrate the brain and every other organ of the body because to advances in catheter technology. As a result, because to advancements in catheter technology, brain aneurysms, which are fatal bulges or flaws in artery walls, can now be treated minimally invasively. The most frequent treatment for the potentially fatal illness involves surgically severing the aneurysm’s base, which requires extensive surgery that requires opening the patient’s skull or forehead to gain access.
Cardiac catheter market segmentation.
Cardiac catheters Market, a segment based on the Product
The category of PTCA balloon catheters is expected to grow at the greatest CAGR and currently holds a dominant position in the cardiac catheter market. The ease of use, safety, and affordability of percutaneous transluminal coronary angioplasty balloon catheters are their motivating reasons. The primary benefit of PTCA is the elimination of the acute postoperative discomforts associated with coronary bypass surgery while reducing morbidity.
Electrophysiology catheters collect electrophysiological signals (ECG) from inside the heart or through the oesophagus using intra-cardiac ECG procedures. Body surface ECG electrodes collect data from a pair of electrodes at the electrophysiology catheter’s tip, which is how they differ from intra-cardiac ECG recording electrodes. The latter displays the electrical activity of the entire heart simultaneously. Electrophysiology catheters are used in practically all heart ablation methods. Additionally, since the FDA approved a number of new products in 2010, the number of cardiac ablation procedures has increased significantly.
A market niche for cardiac catheters based on end users:
In terms of end users, the sector led by ambulatory surgical centres is expected to make the most contribution to the cardiac catheter market.
While ASCs are dedicated to providing patients with the best surgical experience possible, they also offer reasonably priced care to enable patients to save money.
When services are delivered at an ambulatory surgery centre, patient co-pays are typically lowered. An ambulatory surgery centre offers numerous advantages for patients, including quicker and more practical solutions, individualised treatment in a calm and clean atmosphere, a lesser risk of contracting a serious infection (hospital bacterial), and a lower cost than a hospital.
Report Scope
| Feature of the Report | Details |
| Market Size in 2021 | USD 13.5 Billion |
| Projected Market Size in 2030 | USD 25.5 Billion |
| Market Size in 2022 | USD 14.2 Billion |
| CAGR Growth Rate | 7.65% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | Abbott Laboratories, Boston Scientific Corporation, Bard Medical, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic Inc., Becton Dickinson and Company, Edwards Lifesciences Corp., Vascular Solutions Inc., and Others |
| Key Segment | By Product, End User, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Regional Insights
Throughout the anticipated period, North America is anticipated to continue its leading position in the cardiac catheter market. In North America, the catheter market is anticipated to grow the fastest. The prevalence of urological disorders, renal failure, and the number of highly skilled surgeons, among other factors, are mostly to blame for this substantial revenue share.
There will be an increase in PCI procedures in the US, Canada, and Mexico as the patient population that can be treated with PCI reaches saturation; this will happen more quickly in the US and Canada, where the infrastructure is already in place to do PCI procedures, and more slowly in Mexico.
Because to the increased prevalence of A.P. and MI in the country as well as the country’s strong healthcare infrastructure, resources, and skilled experts, the U.S. has one of the highest rates of PCI operations when compared to other countries.
Asia Pacific is predicted to see the market for cardiac catheters’ fastest CAGR growth throughout the projection period. The sector is primarily being pushed by the increased incidence of cardiovascular disease and diabetes. It is also anticipated that emerging economies like China, Japan, South Korea, and India will have significant growth during the forecasted period. Also, a number of regional rivals in China and Japan might encourage regional market expansion.
Despite the widespread need for cardiovascular therapy in South America, the sophistication of the healthcare system is mainly limited to major cities. Hence, the market for cardiac catheters will continue to grow steadily but slowly before plateauing until healthcare infrastructure is strengthened. PCI procedures are progressively rising in the Middle East and Africa, mostly due to issues with the healthcare infrastructure.
New Development
- The Headlamp ultraviolet-A light-based pulmonary catheter received a U.S. patent from the U.S. Patent and Trademark Office in November 2021, according to US pharmaceutical company Aytu BioPharma.
- The UK-based Flume Catheter Company Ltd. announced in November 2021 that the FDA has given the go-ahead for it to launch the FLUME catheter in the United States.
Important market developments in the market for cardiac catheters
Boston Scientific Corporation unveiled the DIRECTSENSE technological tool, which is implanted at the tip of catheters, for the detection, monitoring, and analysis of radiofrequency and energy delivery during cardiac ablation treatments. This new introduction gave the business a technological edge over its competitors and enabled them to broaden its product line.
Key Players
- Abbott Laboratories
- Boston Scientific Corporation
- Bard Medical
- Braun Melsungen AG
- Teleflex Incorporated
- Johnson & Johnson
- Medtronic Inc.
- Becton Dickinson and Company
- Edwards Lifesciences Corp.
- Vascular Solutions Inc.
Segments covered in the report.
By Product
- Electrophysiology Catheters
- PTCA Balloons Catheters
- IVUS Catheters
- PTA Balloons Catheters
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Based on Geography
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Cardiac Catheters Market, (2022 – 2030) (USD Billion)
- 2.2 Global Cardiac Catheters Market : snapshot
- Chapter 3. Global Cardiac Catheters Market – Industry Analysis
- 3.1 Cardiac Catheters Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Unhealthy Lifestyle
- 3.2.2 Growing Aging Population
- 3.2.3 Technology Advancements
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product
- 3.7.2 Market attractiveness analysis By End User
- Chapter 4. Global Cardiac Catheters Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Cardiac Catheters Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Cardiac Catheters Market – Product Analysis
- 5.1 Global Cardiac Catheters Market overview: By Product
- 5.1.1 Global Cardiac Catheters Market share, By Product, 2021 and 2030
- 5.2 Electrophysiology Catheters
- 5.2.1 Global Cardiac Catheters Market by Electrophysiology Catheters, 2022 – 2030 (USD Billion)
- 5.3 PTCA Balloons Catheters
- 5.3.1 Global Cardiac Catheters Market by PTCA Balloons Catheters, 2022 – 2030 (USD Billion)
- 5.4 IVUS Catheters
- 5.4.1 Global Cardiac Catheters Market by IVUS Catheters, 2022 – 2030 (USD Billion)
- 5.5 PTA Balloons Catheters
- 5.5.1 Global Cardiac Catheters Market by PTA Balloons Catheters, 2022 – 2030 (USD Billion)
- 5.1 Global Cardiac Catheters Market overview: By Product
- Chapter 6. Global Cardiac Catheters Market – End User Analysis
- 6.1 Global Cardiac Catheters Market overview: By End User
- 6.1.1 Global Cardiac Catheters Market share, By End User, 2021 and 2030
- 6.2 Hospitals
- 6.2.1 Global Cardiac Catheters Market by Hospitals, 2022 – 2030 (USD Billion)
- 6.3 Ambulatory Surgical Centers
- 6.3.1 Global Cardiac Catheters Market by Ambulatory Surgical Centers, 2022 – 2030 (USD Billion)
- 6.4 Clinics
- 6.4.1 Global Cardiac Catheters Market by Clinics, 2022 – 2030 (USD Billion)
- 6.1 Global Cardiac Catheters Market overview: By End User
- Chapter 7. Cardiac Catheters Market – Regional Analysis
- 7.1 Global Cardiac Catheters Market Regional Overview
- 7.2 Global Cardiac Catheters Market Share, by Region, 2021 & 2030 (USD Billion)
- 7.3. North America
- 7.3.1 North America Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.3.1.1 North America Cardiac Catheters Market, by Country, 2022 – 2030 (USD Billion)
- 7.3.1 North America Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.4 North America Cardiac Catheters Market, by Product, 2022 – 2030
- 7.4.1 North America Cardiac Catheters Market, by Product, 2022 – 2030 (USD Billion)
- 7.5 North America Cardiac Catheters Market, by End User, 2022 – 2030
- 7.5.1 North America Cardiac Catheters Market, by End User, 2022 – 2030 (USD Billion)
- 7.6. Europe
- 7.6.1 Europe Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.6.1.1 Europe Cardiac Catheters Market, by Country, 2022 – 2030 (USD Billion)
- 7.6.1 Europe Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.7 Europe Cardiac Catheters Market, by Product, 2022 – 2030
- 7.7.1 Europe Cardiac Catheters Market, by Product, 2022 – 2030 (USD Billion)
- 7.8 Europe Cardiac Catheters Market, by End User, 2022 – 2030
- 7.8.1 Europe Cardiac Catheters Market, by End User, 2022 – 2030 (USD Billion)
- 7.9. Asia Pacific
- 7.9.1 Asia Pacific Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.9.1.1 Asia Pacific Cardiac Catheters Market, by Country, 2022 – 2030 (USD Billion)
- 7.9.1 Asia Pacific Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.10 Asia Pacific Cardiac Catheters Market, by Product, 2022 – 2030
- 7.10.1 Asia Pacific Cardiac Catheters Market, by Product, 2022 – 2030 (USD Billion)
- 7.11 Asia Pacific Cardiac Catheters Market, by End User, 2022 – 2030
- 7.11.1 Asia Pacific Cardiac Catheters Market, by End User, 2022 – 2030 (USD Billion)
- 7.12. Latin America
- 7.12.1 Latin America Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.12.1.1 Latin America Cardiac Catheters Market, by Country, 2022 – 2030 (USD Billion)
- 7.12.1 Latin America Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.13 Latin America Cardiac Catheters Market, by Product, 2022 – 2030
- 7.13.1 Latin America Cardiac Catheters Market, by Product, 2022 – 2030 (USD Billion)
- 7.14 Latin America Cardiac Catheters Market, by End User, 2022 – 2030
- 7.14.1 Latin America Cardiac Catheters Market, by End User, 2022 – 2030 (USD Billion)
- 7.15. The Middle-East and Africa
- 7.15.1 The Middle-East and Africa Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.15.1.1 The Middle-East and Africa Cardiac Catheters Market, by Country, 2022 – 2030 (USD Billion)
- 7.15.1 The Middle-East and Africa Cardiac Catheters Market, 2022 – 2030 (USD Billion)
- 7.16 The Middle-East and Africa Cardiac Catheters Market, by Product, 2022 – 2030
- 7.16.1 The Middle-East and Africa Cardiac Catheters Market, by Product, 2022 – 2030 (USD Billion)
- 7.17 The Middle-East and Africa Cardiac Catheters Market, by End User, 2022 – 2030
- 7.17.1 The Middle-East and Africa Cardiac Catheters Market, by End User, 2022 – 2030 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Boston Scientific Corporation
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Bard Medical
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 B. Braun Melsungen AG
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Teleflex Incorporated
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Johnson & Johnson
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Medtronic Inc.
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Becton Dickinson and Company
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Edwards Lifesciences Corp.
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Vascular Solutions Inc.
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 and Others
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.1 Abbott Laboratories
List Of Figures
Figures No 1 to 21
List Of Tables
Tables No 1 to 52
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Key players
- Abbott Laboratories
- Boston Scientific Corporation
- Bard Medical
- Braun Melsungen AG
- Teleflex Incorporated
- Johnson & Johnson
- Medtronic Inc.
- Becton Dickinson and Company
- Edwards Lifesciences Corp.
- Vascular Solutions Inc.
- Others
FAQs
“North America” region will lead the global Cardiac Catheters market during the forecast period 2022 to 2030.
The key factors driving the market are unhealthy lifestyles,growing aging population, and technology advancements.
The key players operating in the Cardiac Catheters market are Abbott Laboratories, Boston Scientific Corporation, Bard Medical, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic Inc., Becton Dickinson and Company, Edwards Lifesciences Corp., Vascular Solutions Inc.,
The global Cardiac Catheters market is expanding with a CAGR of approximately 7.65 % during the forecast period (2022 to 2030).
The global Cardiac Catheters market size was valued at USD 13.5 Billion in 2021 and it is projected to reach around USD 25.5 Billion by 2030.